Questcor Pharmaceuticals, Inc. (NASDAQ:QCOR) is a biopharmaceutical company. Questcor primary product is H.P. Acthar Gel (repository corticotropin injection) (Acthar), an injectable drug that is approved by the United States Food and Drug Administration (FDA). Questcor Pharmaceuticals, Inc witnessed volume of 13.97 million shares during last trade however it holds an average trading capacity of 1.25 million shares. QCOR last trade opened at $41.72 reached intraday low of $34.80 and went -14.93% up to close at $35.34.

Read Full Article and Disclaimer at: http://crwewallstreetnewsalert.com/7283/business-news/questcor-pharmaceu...